These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9308798)

  • 1. Ovarian sensitivity to follicle stimulating hormone is blunted in normo-ovulatory women with Down's syndrome.
    Cento RM; Ragusa L; Proto C; Alberti A; Fiore G; Colabucci F; Lanzone A
    Hum Reprod; 1997 Aug; 12(8):1709-13. PubMed ID: 9308798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndrome.
    Cento RM; Ragusa L; Proto C; Alberti A; Fiore G; Soranna L; Colabucci F; Lanzone A
    J Endocrinol Invest; 1998 Jun; 21(6):342-7. PubMed ID: 9699124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian sensitivity to follicle-stimulating hormone during the follicular phase of the human menstrual cycle and in patients with polycystic ovarian syndrome.
    Caruso A; Fortini A; Fulghesu AM; Pistilli E; Cucinelli F; Lanzone A; Mancuso S
    Fertil Steril; 1993 Jan; 59(1):115-20. PubMed ID: 8419197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone enhances estradiol production follicle-stimulating hormone-induced in the early stage of the follicular maturation.
    Lanzone A; Fortini A; Fulghesu AM; Soranna L; Caruso A; Mancuso S
    Fertil Steril; 1996 Dec; 66(6):948-53. PubMed ID: 8941060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.
    Schipper I; de Jong FH; Fauser BC
    Hum Reprod; 1998 Jun; 13(6):1442-8. PubMed ID: 9688368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cycle and hormone changes during perimenopause: the key role of ovarian function.
    Burger HG; Hale GE; Dennerstein L; Robertson DM
    Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine follicle-stimulating hormone treatment of gilts during an altrenogest-synchronized follicular phase: effects on follicle growth, hormone secretion, ovulation, and fertilization.
    Guthrie HD; Pursel VG; Wall RJ
    J Anim Sci; 1997 Dec; 75(12):3246-54. PubMed ID: 9419999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy.
    van Montfrans JM; van Hooff MH; Martens F; Lambalk CB
    Hum Reprod; 2002 Jan; 17(1):44-7. PubMed ID: 11756360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in thecal and granulosa cell LH and FSH receptor content associated with follicular fluid and peripheral plasma gonadotrophin and steroid hormone concentrations in preovulatory follicles of mares.
    Fay JE; Douglas RH
    J Reprod Fertil Suppl; 1987; 35():169-81. PubMed ID: 3119827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon).
    Mitchell R; Buckler HM; Matson P; Lieberman B; Burger HG; Hilton B; Horne G; Dyson M; Robertson WR
    Hum Reprod; 1996 May; 11(5):962-7. PubMed ID: 8671371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmenarchal Down's syndrome: a theoretical model of growth hormone action on ovarian function.
    Cento RM; Proto C; Guido M; Lanzone A
    Gynecol Endocrinol; 2001 Feb; 15(1):81-8. PubMed ID: 11293930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A search for immunoglobulins inhibiting gonadal cell steroidogenesis in premature ovarian failure.
    Lambert A; Weetman AP; McLoughlin J; Wardle C; Sunderland J; Wheatcroft N; Anobile C; Robertson WR
    Hum Reprod; 1996 Sep; 11(9):1871-6. PubMed ID: 8921056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LH-RH testing in men with Down's syndrome.
    Horan RF; Beitins IZ; Bode HH
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):594-600. PubMed ID: 150188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment.
    Cedrin-Durnerin I; Massin N; Galey-Fontaine J; Bry-Gauillard H; Roger M; Lahlou N; Hugues JN
    Hum Reprod; 2006 Nov; 21(11):2941-7. PubMed ID: 16877377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are elevated FSH concentrations in the pre-conceptional period a risk factor for Down's syndrome pregnancies?
    van Montfrans JM; Lambalk CB; van Hooff MH; van Vugt JM
    Hum Reprod; 2001 Jun; 16(6):1270-3. PubMed ID: 11387304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.